Despite improvements in heart failure therapies, hospitalization readmission rates remain
high. Nationally, increasing attention has been directed toward reducing readmission rates …

Abstract Background: In the COAPT (Cardiovascular Outcomes Assessment of the MitraClip
Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial …

Background: Survival and health status (eg, symptoms and quality of life) are key outcomes
in clinical trials of heart failure treatment. However, health status can only be recorded on …

Background Data from recent cardiovascular outcome trials in patients with type 2 diabetes
(T2D) suggest that sodium-glucose cotransporter 2 (SGLT2) inhibitors can prevent …

Aims A 5‐point change in the Kansas City Cardiomyopathy Questionnaire (KCCQ) is
commonly considered to be a clinically significant difference in health status in patients with …

Background Depression is more common in females than in males and is 3–5 times more
prevalent in patients with heart failure (HF) than in the general population. The 9-item …

Purpose: Previous research has shown that poor health-related quality of life (HRQOL) is
associated with adverse long-term prognosis in patients with heart failure (HF); however …

Aims There are indications that economic crises can affect public health. The aim of this
study was to describe characteristics, health status, and socio‐economic status of outpatient …

Background: Psychosocial stress and anger trigger cardiovascular events, but their
relationship to heart failure (HF) exacerbations is unclear. We investigated perceived stress …

Aims Patients with heart failure often have under-recognized symptoms, depression, anxiety,
and poorer spiritual well-being ('QoL domains'). Ideally all patients should have heart failure …